TY - JOUR
T1 - In vivo proton-electron double-resonance imaging of extracellular tumor pH using an advanced nitroxide probe
AU - Samouilov, Alexandre
AU - Efimova, Olga V.
AU - Bobko, Andrey A.
AU - Sun, Ziqi
AU - Petryakov, Sergey
AU - Eubank, Timothy D.
AU - Trofimov, Dmitrii G.
AU - Kirilyuk, Igor A.
AU - Grigor'Ev, Igor A.
AU - Takahashi, Wataru
AU - Zweier, Jay L.
AU - Khramtsov, Valery V.
PY - 2014/1/21
Y1 - 2014/1/21
N2 - A variable radio frequency proton-electron double-resonance imaging (VRF PEDRI) approach for pH mapping of aqueous samples has been recently developed (Efimova et al. J. Magn. Reson. 2011, 209, 227-232). A pH map is extracted from two PEDRI acquisitions performed at electron paramagnetic resonance (EPR) frequencies of protonated and unprotonated forms of a pH-sensitive probe. To translate VRF PEDRI to an in vivo setting, an advanced pH probe was synthesized. Probe deuteration resulted in a narrow spectral line of 1.2 G compared to a nondeuterated analogue line width of 2.1 G allowing for an increase of Overhauser enhancements and reduction in rf power deposition. Binding of the probe to the cell-impermeable tripeptide, glutathione (GSH), allows for targeting to extracellular tissue space for monitoring extracellular tumor acidosis, a prognostic factor in tumor pathophysiology. The probe demonstrated pH sensitivity in the 5.8-7.8 range, optimum for measurement of acidic extracellular tumor pH (pHe). In vivo VRF PEDRI was performed on Met-1 tumor-bearing mice. Compared to normal mammary glands with a neutral mean pHe (7.1 ± 0.1), we observed broader pH distribution with acidic mean pHe (6.8 ± 0.1) in tumor tissue. In summary, VRF PEDRI in combination with a newly developed pH probe provides an analytical approach for spatially resolved noninvasive pHe monitoring, in vivo.
AB - A variable radio frequency proton-electron double-resonance imaging (VRF PEDRI) approach for pH mapping of aqueous samples has been recently developed (Efimova et al. J. Magn. Reson. 2011, 209, 227-232). A pH map is extracted from two PEDRI acquisitions performed at electron paramagnetic resonance (EPR) frequencies of protonated and unprotonated forms of a pH-sensitive probe. To translate VRF PEDRI to an in vivo setting, an advanced pH probe was synthesized. Probe deuteration resulted in a narrow spectral line of 1.2 G compared to a nondeuterated analogue line width of 2.1 G allowing for an increase of Overhauser enhancements and reduction in rf power deposition. Binding of the probe to the cell-impermeable tripeptide, glutathione (GSH), allows for targeting to extracellular tissue space for monitoring extracellular tumor acidosis, a prognostic factor in tumor pathophysiology. The probe demonstrated pH sensitivity in the 5.8-7.8 range, optimum for measurement of acidic extracellular tumor pH (pHe). In vivo VRF PEDRI was performed on Met-1 tumor-bearing mice. Compared to normal mammary glands with a neutral mean pHe (7.1 ± 0.1), we observed broader pH distribution with acidic mean pHe (6.8 ± 0.1) in tumor tissue. In summary, VRF PEDRI in combination with a newly developed pH probe provides an analytical approach for spatially resolved noninvasive pHe monitoring, in vivo.
UR - http://www.scopus.com/inward/record.url?scp=84892712568&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892712568&partnerID=8YFLogxK
U2 - 10.1021/ac402230h
DO - 10.1021/ac402230h
M3 - Article
C2 - 24372284
AN - SCOPUS:84892712568
SN - 0003-2700
VL - 86
SP - 1045
EP - 1052
JO - Analytical Chemistry
JF - Analytical Chemistry
IS - 2
ER -